Registro:

Referencias:

• Stewart, J.A., Reef, S.E., Pellet, P.E., Corey, L., Whitley, R.J., Herpesvirus infections in persons infected with human immunodeficiency virus (1995) Clin Infect Dis, 21, pp. S114-20
• Elion, G.B., Furman, P.A., Fyfe, J.A., De Miranda, P., Beauchamp, L., Schaeffer, H.J., Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine (1977) Proc Natl Acad Sci USA, 74, pp. 5716-5720
• Whitley, R.J., Gnann J.W., Jr., Antiviral therapy (1993) The Human Herpesviruses, pp. 329-348. , Roizman B, Whitley RJ, Lopez C, editors. New York: Raven Press
• Crumpacker, C.S., Schnipper, L.E., Marlowe, S.I., Kowalsky, P.N., Hershey, B.J., Levin, M.J., Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir (1982) N Engl J Med, 306, pp. 343-346
• Erlich, K.S., Millis, J., Chatis, P., Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome (1989) N Engl J Med, 320, pp. 293-296
• Birch, C.J., Tachediian, G., Doherty, R.R., Hayes, K., Gust, I.D., Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome (1990) J Infect Dis, 162, pp. 731-734
• Villamil, S.M., Alche, L.E., Coto, C.E., Inhibition of herpes simplex virus type 1 multiplication by meliacine, a peptide of plant origin (1995) Antiviral Chem Chemother, 6, pp. 239-244
• Andrei, G.M., Couto, A.S., Lederkremer, R.M., Coto, C.E., Purification and partial characterization of an antiviral active peptide from Melia azedarach L (1994) Antiviral Chem Chemother, 5, pp. 105-110
• Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J Immunol Methods, 65, pp. 55-63
• Chou, T.-C., Talalay, P., Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors (1984) Adv Enzyme Regul, 22, pp. 27-55
• Suhnel, J., Evaluation of synergism or antagonism for the combined action of antiviral agents (1990) Antiviral Res, 13, pp. 23-40
• Silber, A.M., Candurra, N.A., Damonte, E.B., The effects of oligosaccharide trimming inhibitors on glycoprotein expression and infectivity of Junin virus (1993) FEMS Microbiol Lett, 109, pp. 39-44
• Hartshorn, K.L., Vogt, M.W., Chou, T.-C., Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha-A interferon (1987) Antimicrob Agents Chemother, 31, pp. 168-172
• Antonelli, G., Dianzani, F., Bellarosa, D., Turriziani, O., Riva, E., Gentile, A., Drug combination of AZT and ddI: Synergism. of action and prevention of appearance of AZT-resistance (1994) Antiviral Chem Chemother, 5, pp. 51-55
• Hartshorn, K.L., Sandstrom, E.G., Neumeyer, D., Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon (1986) Antimicrob Agents Chemother, 30, pp. 189-191
• Schinazi, R.F., Chou, T.-C., Scott, R.T., Yao, X., Nahmias, A.J., Delayed treatment with herpes simplex virus and application of the median effect method of analysis (1986) Antimicrob Agents Chemother, 30, pp. 491-498
• Prichard, M.N., Shipman C.H., Jr., A three-dimensional model to analyze drug-drug interactions (1990) Antiviral Res, 14, pp. 181-206
• Johnson, V.A., Merrill, D.P., Videler, J.A., Two-drug combinations of zidovudine, didanosine, and recombinant interferon-α A inhibit replication of zidovudineresistant human immunodeficiency virus type 1 synergistically in vitro (1991) J Infect Dis, 164, pp. 646-655

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------